default image provider
0 Patient Reviews

Wenxin (Vincent) Xu, MD

Internal Medicine Physician - Medical Oncology

Biography

Dr. Xu received his MD from Harvard Medical School in 2014. He completed residency training in internal medicine at Beth Israel Deaconess Medical Center, followed by fellowship training in hematology and medical oncology also at Beth Israel Deaconess Medical Center. Dr. Xu joined the Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute in 2020. In addition to caring for patients,… Read more ›

Summary

Provider Training

UniversityDegreeFocusGraduated
Harvard Medical SchoolDoctorateOther2014

InstitutionFocusYear
Fellowship - Beth Israel Deaconess Medical Center, Hematology/OncologyOther2020
Residency - Beth Israel Deaconess Medical Center, Internal MedicineOther2017

Specialties

Languages Spoken
English, Mandarin
Medical Specialties
  • Internal Medicine Physician - Sub-Specialty: Medical Oncology

Accepts New Patients: Yes

Payment Options

Payment Details

Reviews

Average Rating: None
Number of Reviews: 0
Most Recent Review: None
Write a Review

Office & Staff Evaluation Not rated

Ease of Getting an Appointment Not rated
Courtesy of Practice Staff Not rated
Office Appearance & Atmosphere Not rated
Handling of Billing Matters Not rated
Average Wait Time Not Rated

Locations

Affiliated Practices

Practice Colleagues

Harshabad (Harsh) Singh, MBBS   -   Internal Medicine Physician
Open Profile
Michael Courage, Pharm D, MBA, BCACP   -   Other Healthcare Provider
Open Profile

Procedures & Services

Procedures & Treatments Offered

    Commonly Prescribed Medications

    Wenxin (Vincent) Xu, MD has not yet listed the medications that he commonly prescribes.

    Accepted Insurance

    Accepted Insurance

    Wenxin (Vincent) Xu, MD has not yet specified the insurance plans he accepts.
     

    We use cookies and limited processing of your personal information for our website and services to function. By using our site, you agree to our use of cookies and our privacy policy.